RISK FACTORS HDL-cholesterol levels and mortality in patients with ESRD

被引：5
作者：
Vaziri, Nosratola D. [1 ]
机构：
[1] UC Irvine Med Ctr, Div Nephrol & Hypertens, City Tower,4th Floor, Orange, CA 92868 USA
来源：
NATURE REVIEWS NEPHROLOGY | 2014年 / 10卷 / 11期
关键词：
HIGH-DENSITY-LIPOPROTEIN; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS;
D O I：
10.1038/nrneph.2014.169
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In the general population, risk of cardiovascular disease is inversely associated with HDL-cholesterol levels. However, a new post hoc analysis of data from the German Diabetes Dialysis study reports no correlation between HDL cholesterol and mortality among patients on dialysis—a phenomenon that the authors attribute to HDL dysfunction.
引用
收藏
页码：621 / 623
页数：3
相关论文
共 10 条
  • [1] Uremia Alters HDL Composition and Function
    Holzer, Michael
    Birner-Gruenberger, Ruth
    Stojakovic, Tatjana
    El-Gamal, Dalia
    Binder, Veronika
    Wadsack, Christian
    Heinemann, Akos
    Marsche, Gunther
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (09): : 1631 - 1641
  • [2] Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients
    Honda, Hirokazu
    Ueda, Masashi
    Kojima, Shiho
    Mashiba, Shinichi
    Michihata, Tetsuo
    Takahashi, Keiko
    Shishido, Kanji
    Akizawa, Tadao
    [J]. ATHEROSCLEROSIS, 2012, 220 (02) : 493 - 501
  • [3] Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients
    Moradi, Hamid
    Streja, Elani
    Kashyap, Moti L.
    Vaziri, Nosratola D.
    Fonarow, Gregg C.
    Kalantar-Zadeh, Kamyar
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (08) : 1554 - 1562
  • [4] Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein
    Shao, Baohai
    Oda, Michael N.
    Oram, John F.
    Heinecke, Jay W.
    [J]. CURRENT OPINION IN CARDIOLOGY, 2006, 21 (04) : 322 - 328
  • [5] HDL Cholesterol, Apolipoproteins, and Cardiovascular Risk in Hemodialysis Patients
    Silbernagel, Guenther
    Genser, Bernd
    Drechsler, Christiane
    Scharnagl, Hubert
    Grammer, Tanja B.
    Stojakovic, Tatjana
    Krane, Vera
    Ritz, Eberhard
    Wanner, Christoph
    Maerz, Winfried
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (02): : 484 - 492
  • [6] Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
    Vaziri, ND
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (02) : F262 - F272
  • [7] Lipotoxicity and Impaired High Density Lipoprotein-Mediated Reverse Cholesterol Transport in Chronic Kidney Disease
    Vaziri, Nosratola D.
    [J]. JOURNAL OF RENAL NUTRITION, 2010, 20 (05) : S35 - S43
  • [8] HDL metabolism and activity in chronic kidney disease
    Vaziri, Nosratola D.
    Navab, Mohamad
    Fogelman, Alan M.
    [J]. NATURE REVIEWS NEPHROLOGY, 2010, 6 (05) : 287 - 296
  • [9] Serum Amyloid A in Uremic HDL Promotes Inflammation
    Weichhart, Thomas
    Kopecky, Chantal
    Kubicek, Markus
    Haidinger, Michael
    Doeller, Dominik
    Katholnig, Karl
    Suarna, Cacang
    Eller, Philipp
    Toelle, Markus
    Gerner, Christopher
    Zlabinger, Gerhard J.
    van der Giet, Markus
    Hoerl, Walter H.
    Stocker, Roland
    Saeemann, Marcus D.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (05): : 934 - 947
  • [10] Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
    Yamamoto, Suguru
    Yancey, Patricia G.
    Ikizler, Alp
    Jerome, W. Gray
    Kaseda, Ryohei
    Cox, Brian
    Bian, Aihua
    Shintani, Ayumi
    Fogo, Agnes B.
    Linton, MacRae F.
    Fazio, Sergio
    Kon, Valentina
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (23) : 2372 - 2379
1